Clinical trial
PI Vs. NNRTI Based Therapy for HIV Advanced Disease
NCT00162643 · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Other · Unknown status
Key facts
| NCT number | NCT00162643 |
|---|---|
| Title | PI Vs. NNRTI Based Therapy for HIV Advanced Disease |
| Official title | Boosted PI VS. NNRTI Based Therapy as Initial Treatment for HIV-1 Infected Patients With Advanced Disease |
| Lead sponsor | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Other |
| Collaborators | National Council of Science and Technology, Mexico Instituto Mexicano del Seguro Social |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome |
| Intervention type | Drug |
| Interventions | zidovudine+lamivudine+lopinavir/ritonavir, zidovudine + lamivudine + efavirenz |
| Enrollment | 300 |
| Start date | Dec 1, 2004 |
| Completion | Dec 1, 2007 |
| First posted | Sep 13, 2005 |
| Last update posted | Sep 14, 2006 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: